International Stem Cell (OTCQB: ISCO) (aka ISCO) is Profiled in this Database

Updated At 15 Dec, 2011

Partial description of this company

The world\'s first homozygous parthenogenetic stem cell lines that can provide therapeutic cells with the potential to be transplanted into hundreds of millions of individuals of differing ages and racial backgrounds with minimal risk of immune rejection

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of International Stem Cell (OTCQB: ISCO) (aka ISCO) plus 4917 other startups.

Start Free 7 Day Trial Now

Learn More About International Stem Cell (OTCQB: ISCO) (aka ISCO)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation